Published in J Lab Clin Med on March 01, 1997
Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood (2010) 2.00
Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood (2013) 1.64
Phenotypic heterogeneity in the Gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost (2008) 0.84
Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet (1967) 5.38
The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest (1968) 3.66
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest (1973) 2.94
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest (1973) 2.71
Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med (1974) 2.44
Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31
Spatiotemporal patterns of beta desynchronization and gamma synchronization in corticographic data during self-paced movement. Clin Neurophysiol (2003) 2.29
Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res (1978) 2.14
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood (1994) 2.12
Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol (1984) 2.06
Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem (2000) 1.97
Transient arthritis after rubella vaccination. Am J Dis Child (1969) 1.86
Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med (1974) 1.86
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest (1977) 1.85
Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med (1975) 1.69
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63
Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography. Thromb Diath Haemorrh (1972) 1.61
Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol (1970) 1.57
Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4. J Biol Chem (1976) 1.52
Secretable storage pools in platelets. Annu Rev Med (1979) 1.49
Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science (1973) 1.49
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Aspirin--a dangerous drug? JAMA (1974) 1.47
Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med (1978) 1.46
Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med (1971) 1.46
Visualization of significant ERD/ERS patterns in multichannel EEG and ECoG data. Clin Neurophysiol (2002) 1.44
Long-term culture of human endothelial cells. In Vitro (1983) 1.39
Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood (1978) 1.39
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Development of a radioimmunoassay for human platelet factor 4. Thromb Res (1977) 1.26
Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Am J Med (1972) 1.25
Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia. J Lab Clin Med (1968) 1.24
Evaluation of an occupational health and safety management system performance measurement tool-II: scoring methods and field study sites. AIHA J (Fairfax, Va) (2002) 1.24
Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23
Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23
Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood (1986) 1.21
Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest (1984) 1.20
Localization of factor-VIII-related antigen in human vascular subendothelium. Blood (1980) 1.20
Safety of invasive procedures in patients with the coagulopathy of liver disease. Clin Lab Haematol (1989) 1.20
Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation (1980) 1.19
A familialdefect in platelet function associated with imapired release of adenosine diphosphate. N Engl J Med (1969) 1.18
Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease. J Lab Clin Med (1979) 1.17
A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease. Prostaglandins (1973) 1.17
Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med (1967) 1.16
Isolated deficiency of platelet procoagulant activity. Am J Med (1979) 1.15
Asymptomatic sensorimotor polyneuropathy in workers exposed to elemental mercury. Neurology (1982) 1.14
Red blood cells: their dual role in thrombus formation. Science (1980) 1.13
Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest (1986) 1.13
Thrombocytopathia due to abnormalities in platelet release reaction--studies on six unrelated patients. Blood (1972) 1.12
Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood (1997) 1.12
Multimeric composition of endothelial cell-derived von Willebrand factor. Blood (1989) 1.09
Learning and performance of able-bodied individuals using scanning systems with and without word prediction. Assist Technol (1994) 1.07
Immunoglobulin G is a platelet alpha granule-secreted protein. J Clin Invest (1985) 1.07
Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost (1981) 1.07
Optimal techniques for the immunocytochemical demonstration of beta-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets. Histochem J (1984) 1.06
Editorial: Platelet function tests and their interpretation. J Lab Clin Med (1976) 1.06
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Von Willebrand's disease--diagnostic criteria. Blood (1968) 1.06
Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol (1988) 1.06
Platelet activation and secretion associated with emotional stress. Circulation (1985) 1.05
Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med (1986) 1.05
Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood (1985) 1.05
Electrical stimulation for pressure sore prevention and wound healing. Assist Technol (2000) 1.04
Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. J Clin Invest (1974) 1.03
Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. J Clin Invest (1980) 1.02
Antiplatelet therapy (first of two parts). N Engl J Med (1978) 1.02
Content and thrombin-induced release of acid hydrolases in gel-filtered platelets from patients with storage pool disease. Blood (1975) 1.02
Growth of Plasmodium falciparum in human erythrocytes containing abnormal membrane proteins. Proc Natl Acad Sci U S A (1990) 1.02
Binding of platelet factor four (PF 4) to glomerular polyanion. Kidney Int (1984) 1.01
Properties of the platelet retention (von Willebrand) factor and its similarity to the antihemophilic factor (AHF). Blood (1973) 1.01
The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway. Br J Haematol (1991) 0.99
Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood (1985) 0.97
Thromboembolism--a continuing challenge. N Engl J Med (1970) 0.97
Electron microscopic localization of factor-VIII-related antigen in adult human blood vessels. Blood (1982) 0.96
Platelet activating factor (PAF) induced release of platelet factor 4 (PF4) in vitro and during IgE anaphylaxis in the rabbit. J Immunol (1979) 0.96
Progress in characterization of pre-implantation factor in embryo cultures and in vivo. Am J Reprod Immunol (1999) 0.96
Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. J Lab Clin Med (1982) 0.96
The effect of shear rate on platelet interaction with subendothelium exposed to citrated human blood. Microvasc Res (1980) 0.96
Elemental mercury exposure: peripheral neurotoxicity. Br J Ind Med (1982) 0.96
Release of human platelet factor V activity is induced by both collagen and ADP and is inhibited by aspirin. Blood (1980) 0.95
Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment. J Lab Clin Med (1983) 0.95
Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med (1975) 0.94
Ultrastructural findings in storage pool disease and aspirin-like defects of platelets. Am J Pathol (1973) 0.94
Thrombin generation and secretion of platelet Factor 4 during blood clotting. J Clin Invest (1978) 0.94
The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies. J Lab Clin Med (1967) 0.94
Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb Haemost (1977) 0.93
Stem cell-mediated muscle regeneration and repair in aging and neuromuscular diseases. Eur J Histochem (2007) 0.92
Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest (1994) 0.92
A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia. Leuk Res (1997) 0.91
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis. Am Heart J (1976) 0.90